On May 6, 2024, Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company emphasized the importance of each vote, noting that more than 95% of votes received to date were in favor of the proposal, but a majority of outstanding shares is required for approval. Assure's CEO, John Farlinger, highlighted the necessity for stockholders with smaller positions to vote, as larger stockholders alone cannot ensure the proposal's passage. The increase in authorized shares is critical for the company's capital needs, and failure...Show More

On May 6, 2024, Assure Holdings Corp., a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company emphasized the importance of each vote, noting that more than 95% of votes received to date were in favor of the proposal, but a majority of outstanding shares is required for approval. Assure's CEO, John Farlinger, highlighted the necessity for stockholders with smaller positions to vote, as larger stockholders alone cannot ensure the proposal's passage. The increase in authorized shares is critical for the company's capital needs, and failure to approve the proposal could delay the company's plans. Assure has filed a definitive proxy statement with the SEC and has provided information on how stockholders can vote. The company also mentioned an ongoing proposed transaction with Danam Health Inc., for which materials have been filed with the SEC, including a registration statement containing a prospectus and a proxy statement.